LEADING PHARMA LLC FDA Approval ANDA 073250

ANDA 073250

LEADING PHARMA LLC

FDA Drug Application

Application #073250

Application Sponsors

ANDA 073250LEADING PHARMA LLC

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL10MG0NIFEDIPINENIFEDIPINE

FDA Submissions

ORIG1AP1991-10-08
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1996-07-31
LABELING; LabelingSUPPL3AP1996-07-26
LABELING; LabelingSUPPL4AP1997-01-24
LABELING; LabelingSUPPL5AP1998-06-12
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1998-12-31
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2001-06-19
LABELING; LabelingSUPPL10AP2018-05-21STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL6Null0
SUPPL7Null0
SUPPL10Null7

TE Codes

001PrescriptionAB

CDER Filings

LEADING PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 73250
            [companyName] => LEADING PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NIFEDIPINE","activeIngredients":"NIFEDIPINE","strength":"10MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NIFEDIPINE","submission":"NIFEDIPINE","actionType":"10MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.